Novo Nordisk Swallows Dicerna In $3.3B Buyout: All You Need To Know
Why Novo Nordisk (NVO) Is Buying Dicerna Pharmaceuticals (DRNA) For $3.3 Billion
Novo Nordisk strikes $3.3 billion to buy research partner Dicerna Pharmaceuticals
Dicerna Pharmaceuticals: Q3 Earnings Insights
Dicerna Posts Mixed Nedosiran Data In Rare Kidney Disease Trial